View of Optimizing the antitumor efficacy of cisplatin low doses by the co-treatment with ethylenediamine tetra acetic acid in EAC-bearing mice

Return to Article Details Optimizing the antitumor efficacy of cisplatin low doses by the co-treatment with ethylenediamine tetra acetic acid in EAC-bearing mice Download Download PDF